These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3211092)

  • 21. Effects of fluoride on bone in chronic renal failure.
    Lough J; Noonan R; Gagnon R; Kaye M
    Arch Pathol; 1975 Sep; 99(9):484-7. PubMed ID: 1164250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnesium status in chronically haemodialyzed patients: the role of dialysate magnesium concentration.
    Gonella M; Calabrese G
    Magnes Res; 1989 Dec; 2(4):259-65. PubMed ID: 2701862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients.
    Faugere MC; Malluche HH
    Kidney Int; 1986 Nov; 30(5):717-22. PubMed ID: 2431192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization.
    Cournot-Witmer G; Zingraff J; Plachot JJ; Escaig F; Lefèvre R; Boumati P; Bourdeau A; Garabédian M; Galle P; Bourdon R; Drüeke T; Balsan S
    Kidney Int; 1981 Sep; 20(3):375-8. PubMed ID: 7300127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of low magnesium dialysate on plasma, ultrafiltrable, erythrocyte and bone magnesium concentrations from patients on maintenance haemodialysis.
    Catto GR; Reid IW; MacLeod M
    Nephron; 1974; 13(5):372-81. PubMed ID: 4431548
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of decreasing dialysate magnesium in patients with chronic renal failure.
    Burnell JM; Teubner E
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():191-8. PubMed ID: 1029885
    [No Abstract]   [Full Text] [Related]  

  • 27. Relationship between hair, serum and bone aluminium in hemodialyzed patients.
    Chappuis P; de Vernejoul MC; Paolaggi F; Rousselet F
    Clin Chim Acta; 1989 Feb; 179(3):271-8. PubMed ID: 2714000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum magnesium and nerve conduction velocity in uraemic patients on chronic haemodialysis.
    Cisari C; Gasco P; Calabrese G; Pratesi G; Gonella M
    Magnes Res; 1989 Dec; 2(4):267-9. PubMed ID: 2642071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypermagnesemia in hemodialysis due to excessive concentration of the element in the dialysate].
    Switlik I; Dziewanowski K
    Wiad Lek; 1990 Mar 1-15; 43(5-6):227-31. PubMed ID: 2195778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical and morphological aspects of bone tissue in chronic renal failure.
    Maschio G; Bonucci E; Mioni G; D'Angelo A; Ossi E; Valvo E; Lupo A
    Nephron; 1974; 12(6):437-48. PubMed ID: 4842689
    [No Abstract]   [Full Text] [Related]  

  • 31. Aluminum-related bone disease. Correlation between symptoms, osteoid volume, and aluminum staining.
    Connor MO; Garrett P; Dockery M; Donohoe JF; Doyle GD; Carmody M; Dervan PA
    Am J Clin Pathol; 1986 Aug; 86(2):168-74. PubMed ID: 2426938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous Observation of Serum Total Magnesium Level in Patients Undergoing Hemodialysis.
    Yang W; Wang E; Chen W; Chen C; Chen S
    Blood Purif; 2021; 50(2):196-204. PubMed ID: 32866952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in bone histoquantitative parameters and histochemical staining reactions for aluminium in a group of patients with chronic renal failure following a reduction in the aluminium concentration of the haemodialysis fluid.
    McClure J; Fazzalari NL; Fassett RG; Pugsley PG
    J Clin Pathol; 1984 Jul; 37(7):743-7. PubMed ID: 6747011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma and tissue levels of magnesium in chronically hemodialyzed patients: effects of dialysate magnesium levels.
    Gonella M
    Nephron; 1983; 34(3):141-5. PubMed ID: 6877445
    [No Abstract]   [Full Text] [Related]  

  • 35. Some applications of neutron activation for the analysis of human bone.
    Goode GC; Howard CM; Wilson AR; Parsons V
    Anal Chim Acta; 1972 Feb; 58(2):363-8. PubMed ID: 5014208
    [No Abstract]   [Full Text] [Related]  

  • 36. Deranged Ca, Al and Mg content in the tissues of patients with chronic renal failure, as measured by non-destructive neutron activation analysis.
    Marumo F; Nakamura M; Sato N; Shimada H; Tsukamoto S; Iwanami S
    Int J Artif Organs; 1985 Nov; 8(6):319-24. PubMed ID: 4077290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone magnesium pools in uremia.
    Alfrey AC; Miller NL
    J Clin Invest; 1973 Dec; 52(12):3019-27. PubMed ID: 4584344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone changes in alcoholic liver cirrhosis. A histomorphometrical analysis of 52 cases.
    Jorge-Hernandez JA; Gonzalez-Reimers CE; Torres-Ramirez A; Santolaria-Fernandez F; Gonzalez-Garcia C; Batista-Lopez JN; Pestana-Pestana M; Hernandez-Nieto L
    Dig Dis Sci; 1988 Sep; 33(9):1089-95. PubMed ID: 3044713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes of Ca and Mg concentrations in plasma and erythrocytes during hemodialysis].
    Paschen K; Henning HV; Quellhorst E; Scheler F
    Klin Wochenschr; 1971 Dec; 49(24):1314-8. PubMed ID: 5138341
    [No Abstract]   [Full Text] [Related]  

  • 40. A case of hypermagnesemia accompanied by hypercalcemia induced by a magnesium laxative in a hemodialysis patient.
    Matsuo H; Nakamura K; Nishida A; Kubo K; Nakagawa R; Sumida Y
    Nephron; 1995; 71(4):477-8. PubMed ID: 8587637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.